4 results match your criteria: "National Research Council-Institute for Genetic and Biomedical Research[Affiliation]"
Front Aging
June 2023
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Different from inflammatory arthritis, where biologicals and targeted synthetic molecules have revolutionized the disease course, no drug has demonstrated a disease modifying activity in osteoarthritis, which remains one of the most common causes of disability and chronic pain worldwide. The pharmacological therapy of osteoarthritis is mainly directed towards symptom and pain relief, and joint replacement is still the only curative strategy. Elucidating the disease pathophysiology is essential to understand which mechanisms can be targeted by innovative therapies.
View Article and Find Full Text PDFInt J Mol Sci
January 2023
Milan Unit, National Research Council-Institute for Genetic and Biomedical Research, 20138 Milan, Italy.
Upon infection, severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is predicted to interact with diverse cellular functions, such as the nonsense-mediated decay (NMD) pathway, as suggested by the identification of the core NMD factor upframeshift-1 (UPF1) in the SARS-CoV-2 interactome, and the retrograde transport from the Golgi to the endoplasmic reticulum (ER) through the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), where coronavirus assembly occurs. Here, we investigated the expression and localization of the neuroblastoma-amplified sequence (NBAS) protein, a UPF1 partner for the NMD at the ER, participating also in retrograde transport, and of its functional partners, at early time points after SARS-CoV-2 infection of the human lung epithelial cell line Calu3. We found a significant decrease of DExH-Box Helicase 34 (, suppressor with morphogenetic effect on genitalia 5 (, and expression at 6 h post-infection, followed by a significant increase of these genes and also and at 9 h post-infection.
View Article and Find Full Text PDFFront Immunol
December 2022
IRCCS Humanitas Research Hospital, Rozzano, Italy.
Osteomyelitis (OM) is an infectious disease of the bone predominantly caused by the opportunistic bacterium (). Typically established upon hematogenous spread of the pathogen to the musculoskeletal system or contamination of the bone after fracture or surgery, osteomyelitis has a complex pathogenesis with a critical involvement of both osteal and immune components. Colonization of the bone by is traditionally proposed to induce functional inhibition and/or apoptosis of osteoblasts, alteration of the RANKL/OPG ratio in the bone microenvironment and activation of osteoclasts; all together, these events locally subvert tissue homeostasis causing pathological bone loss.
View Article and Find Full Text PDFPathogens
July 2021
IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy.
Osteomyelitis (OM) is an infectious disease of the bone primarily caused by the opportunistic pathogen (SA). This Gram-positive bacterium has evolved a number of strategies to evade the immune response and subvert bone homeostasis, yet the underlying mechanisms remain poorly understood. OM has been modeled in vitro to challenge pathogenetic hypotheses in controlled conditions, thus providing guidance and support to animal experimentation.
View Article and Find Full Text PDF